FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.6  |  FHIR Version n/a  User: [n/a]

32570271000036106: Australian English language reference set (foundation metadata concept)

Status: current, Primitive. Date: 25-Dec 2013. Module: Australian common model component extension

Descriptions:

Id Description Lang Type Status Case? Module
108642501000036114 Australian English en Synonym Active Case sensitive Australian common model component extension
108644301000036110 Australian English language reference set (foundation metadata concept) en Fully specified name Active Case sensitive Australian common model component extension
108644311000036112 Australian English language reference set en Synonym Active Case sensitive Australian common model component extension
2171000036114 Australian dialect reference set en Synonym Active Case sensitive Australian common model component extension
3306431000168118 ADRS - Australian dialect reference set en Synonym Active Case sensitive Australian common model component extension

943353 members. Search Members:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Australian dialect reference set Is a English true Inferred relationship Some
Members acceptabilityId
tiotropium + olodaterol Preferred
tiotropium 13 microgram powder for inhalation, 30 capsules Preferred
tiotropium 13 microgram powder for inhalation, capsule Preferred
tiotropium 18 microgram powder for inhalation, 1 capsule Preferred
tiotropium 18 microgram powder for inhalation, 10 capsules Preferred
tiotropium 18 microgram powder for inhalation, 150 capsules Preferred
tiotropium 18 microgram powder for inhalation, 30 capsules Preferred
tiotropium 18 microgram powder for inhalation, 300 capsules Preferred
tiotropium 18 microgram powder for inhalation, 60 capsules Preferred
tiotropium 2.5 microgram/actuation + olodaterol 2.5 microgram/actuation inhalation solution, 3 x 60 actuations Preferred
tiotropium 2.5 microgram/actuation + olodaterol 2.5 microgram/actuation inhalation solution, 60 actuations Preferred
tiotropium 2.5 microgram/actuation + olodaterol 2.5 microgram/actuation inhalation solution, actuation Preferred
tiotropium 2.5 microgram/actuation inhalation solution, 3 x 60 actuations Preferred
tiotropium 2.5 microgram/actuation inhalation solution, 60 actuations Preferred
tiotropium 2.5 microgram/actuation inhalation solution, actuation Preferred
tipiracil Preferred
tipranavir Preferred
tipranavir Preferred
tipranavir 100 mg/mL oral liquid Preferred
tipranavir 100 mg/mL oral liquid, 95 mL Preferred
tipranavir 250 mg capsule Preferred
tipranavir 250 mg capsule, 120 Preferred
tirofiban Preferred
tirofiban Preferred
tirofiban 12.5 mg/250 mL injection, 250 mL bag Preferred
tirofiban 12.5 mg/250 mL injection, bag Preferred
tirofiban 12.5 mg/50 mL injection, 50 mL vial Preferred
tirofiban 12.5 mg/50 mL injection, vial Preferred
tirofiban 25 mg/500 mL injection, 500 mL bag Preferred
tirofiban 25 mg/500 mL injection, bag Preferred
tirzepatide Preferred
tirzepatide Preferred
tirzepatide 10 mg/0.5 mL injection, 2 x 0.5 mL pen devices Preferred
tirzepatide 10 mg/0.5 mL injection, 4 x 0.5 mL pen devices Preferred
tirzepatide 10 mg/0.5 mL injection, pen device Preferred
tirzepatide 12.5 mg/0.5 mL injection, 2 x 0.5 mL pen devices Preferred
tirzepatide 12.5 mg/0.5 mL injection, 4 x 0.5 mL pen devices Preferred
tirzepatide 12.5 mg/0.5 mL injection, pen device Preferred
tirzepatide 15 mg/0.5 mL injection, 2 x 0.5 mL pen devices Preferred
tirzepatide 15 mg/0.5 mL injection, 4 x 0.5 mL pen devices Preferred
tirzepatide 15 mg/0.5 mL injection, pen device Preferred
tirzepatide 2.5 mg/0.5 mL injection, 2 x 0.5 mL pen devices Preferred
tirzepatide 2.5 mg/0.5 mL injection, 4 x 0.5 mL pen devices Preferred
tirzepatide 2.5 mg/0.5 mL injection, pen device Preferred
tirzepatide 5 mg/0.5 mL injection, 2 x 0.5 mL pen devices Preferred
tirzepatide 5 mg/0.5 mL injection, 4 x 0.5 mL pen devices Preferred
tirzepatide 5 mg/0.5 mL injection, pen device Preferred
tirzepatide 7.5 mg/0.5 mL injection, 2 x 0.5 mL pen devices Preferred
tirzepatide 7.5 mg/0.5 mL injection, 4 x 0.5 mL pen devices Preferred
tirzepatide 7.5 mg/0.5 mL injection, pen device Preferred
titanium Preferred
titanium Preferred
titanium dioxide Preferred
titanium dioxide + zinc oxide Preferred
titanium dioxide 8.5% cream Preferred
titanium dioxide 8.5% cream, 75 g Preferred
titanium dioxide 9.8% + zinc oxide 2% cream Preferred
titanium dioxide 9.8% + zinc oxide 2% cream, 200 g Preferred
titanium dioxide 9.8% + zinc oxide 2% cream, 75 g Preferred
titanium dioxide 9.8% + zinc oxide 2% lotion Preferred
titanium dioxide 9.8% + zinc oxide 2% lotion, 200 g Preferred
titanium dioxide 9.8% + zinc oxide 2% lotion, 75 g Preferred
tixagevimab Preferred
tixagevimab Preferred
tixagevimab 150 mg/1.5 mL injection [1.5 mL vial] (&) cilgavimab 150 mg/1.5 mL injection [1.5 mL vial], 1 pack Preferred
tixagevimab 150 mg/1.5 mL injection, vial Preferred
tobramycin Preferred
tobramycin Preferred
tobramycin 0.3% eye drops Preferred
tobramycin 0.3% eye drops, 5 mL Preferred
tobramycin 0.3% eye ointment Preferred
tobramycin 0.3% eye ointment, 3.5 g Preferred
tobramycin 20 mg/2 mL injection, 5 x 2 mL vials Preferred
tobramycin 20 mg/2 mL injection, vial Preferred
tobramycin 28 mg powder for inhalation, 1 capsule Preferred
tobramycin 28 mg powder for inhalation, 224 capsules Preferred
tobramycin 28 mg powder for inhalation, 56 capsules Preferred
tobramycin 300 mg/5 mL inhalation solution, 4 x 5 mL ampoules Preferred
tobramycin 300 mg/5 mL inhalation solution, 56 x 5 mL ampoules Preferred
tobramycin 300 mg/5 mL inhalation solution, 8 x 5 mL ampoules Preferred
tobramycin 300 mg/5 mL inhalation solution, ampoule Preferred
tobramycin 500 mg/5 mL injection, 10 x 5 mL vials Preferred
tobramycin 500 mg/5 mL injection, vial Preferred
tobramycin 80 mg/2 mL injection, 10 x 2 mL vials Preferred
tobramycin 80 mg/2 mL injection, 2 mL vial Preferred
tobramycin 80 mg/2 mL injection, 5 x 2 mL ampoules Preferred
tobramycin 80 mg/2 mL injection, 5 x 2 mL vials Preferred
tobramycin 80 mg/2 mL injection, ampoule Preferred
tobramycin 80 mg/2 mL injection, vial Preferred
tocilizumab Preferred
tocilizumab Preferred
tocilizumab 162 mg/0.9 mL injection, 0.9 mL pen device Preferred
tocilizumab 162 mg/0.9 mL injection, 0.9 mL syringe Preferred
tocilizumab 162 mg/0.9 mL injection, 4 x 0.9 mL pen devices Preferred
tocilizumab 162 mg/0.9 mL injection, 4 x 0.9 mL syringes Preferred
tocilizumab 162 mg/0.9 mL injection, pen device Preferred
tocilizumab 162 mg/0.9 mL injection, syringe Preferred
tocilizumab 200 mg/10 mL injection, 10 mL vial Preferred
tocilizumab 200 mg/10 mL injection, 4 x 10 mL vials Preferred
tocilizumab 200 mg/10 mL injection, vial Preferred
tocilizumab 400 mg/20 mL injection, 20 mL vial Preferred

Start Previous Page 9411 of 9434 Next End

Reference Sets

Reference set descriptor

Back to Start